Robert Wasserman
Stock Analyst at Benchmark
(3.52)
# 862
Out of 4,944 analysts
113
Total ratings
47.66%
Success rate
5.29%
Average return
Main Sectors:
Stocks Rated by Robert Wasserman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TECH Bio-Techne | Reiterates: Buy | $75 | $54.71 | +37.09% | 7 | Jun 5, 2025 | |
| KMDA Kamada | Reiterates: Buy | $15 | $7.39 | +102.98% | 2 | May 15, 2025 | |
| OABI OmniAb | Reiterates: Buy | $6 | $2.05 | +192.68% | 9 | May 12, 2025 | |
| ITGR Integer Holdings | Maintains: Buy | $150 → $140 | $109.58 | +27.76% | 11 | Apr 25, 2025 | |
| XOMA XOMA Royalty | Initiates: Buy | $35 | $30.90 | +13.27% | 1 | Apr 17, 2025 | |
| IPA ImmunoPrecise Antibodies | Reiterates: Speculative Buy | $3 | $1.99 | +50.75% | 6 | Apr 1, 2025 | |
| ABCL AbCellera Biologics | Reiterates: Hold | n/a | $4.58 | - | 6 | Mar 3, 2025 | |
| HALO Halozyme Therapeutics | Reiterates: Buy | $75 | $65.13 | +15.15% | 9 | Feb 20, 2025 | |
| BLFS BioLife Solutions | Reiterates: Buy | $30 | $25.68 | +16.82% | 6 | Dec 19, 2024 | |
| ANEB Anebulo Pharmaceuticals | Reiterates: Speculative Buy | $8 | $2.40 | +233.33% | 6 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $5 | $4.16 | +20.19% | 3 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $12 | $8.79 | +36.52% | 17 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $3.05 | - | 7 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $127.15 | - | 3 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $12 | $0.29 | +4,037.93% | 6 | Jul 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $45 | $49.20 | -8.54% | 6 | May 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $4 | $5.25 | -23.81% | 1 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $4 | $0.23 | +1,654.39% | 1 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $75 | $1.95 | +3,746.35% | 2 | Apr 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $209.14 | - | 3 | Oct 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $580 | $484.79 | +19.64% | 1 | Jul 16, 2021 |
Bio-Techne
Jun 5, 2025
Reiterates: Buy
Price Target: $75
Current: $54.71
Upside: +37.09%
Kamada
May 15, 2025
Reiterates: Buy
Price Target: $15
Current: $7.39
Upside: +102.98%
OmniAb
May 12, 2025
Reiterates: Buy
Price Target: $6
Current: $2.05
Upside: +192.68%
Integer Holdings
Apr 25, 2025
Maintains: Buy
Price Target: $150 → $140
Current: $109.58
Upside: +27.76%
XOMA Royalty
Apr 17, 2025
Initiates: Buy
Price Target: $35
Current: $30.90
Upside: +13.27%
ImmunoPrecise Antibodies
Apr 1, 2025
Reiterates: Speculative Buy
Price Target: $3
Current: $1.99
Upside: +50.75%
AbCellera Biologics
Mar 3, 2025
Reiterates: Hold
Price Target: n/a
Current: $4.58
Upside: -
Halozyme Therapeutics
Feb 20, 2025
Reiterates: Buy
Price Target: $75
Current: $65.13
Upside: +15.15%
BioLife Solutions
Dec 19, 2024
Reiterates: Buy
Price Target: $30
Current: $25.68
Upside: +16.82%
Anebulo Pharmaceuticals
Nov 19, 2024
Reiterates: Speculative Buy
Price Target: $8
Current: $2.40
Upside: +233.33%
Nov 12, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $4.16
Upside: +20.19%
Nov 7, 2024
Maintains: Buy
Price Target: $8 → $12
Current: $8.79
Upside: +36.52%
Nov 4, 2024
Reiterates: Hold
Price Target: n/a
Current: $3.05
Upside: -
Aug 5, 2024
Reiterates: Hold
Price Target: n/a
Current: $127.15
Upside: -
Jul 11, 2024
Reiterates: Speculative Buy
Price Target: $12
Current: $0.29
Upside: +4,037.93%
May 29, 2024
Reiterates: Buy
Price Target: $45
Current: $49.20
Upside: -8.54%
Mar 7, 2024
Reiterates: Speculative Buy
Price Target: $4
Current: $5.25
Upside: -23.81%
Mar 6, 2024
Reiterates: Speculative Buy
Price Target: $4
Current: $0.23
Upside: +1,654.39%
Apr 6, 2023
Reiterates: Speculative Buy
Price Target: $75
Current: $1.95
Upside: +3,746.35%
Oct 24, 2022
Downgrades: Hold
Price Target: n/a
Current: $209.14
Upside: -
Jul 16, 2021
Initiates: Buy
Price Target: $580
Current: $484.79
Upside: +19.64%